CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Asthma - Management
What advice should I give to people using a long-acting beta2-agonist?
- Advise people who are starting treatment with a long-acting beta2-agonist (LABA) to report any deterioration in symptoms [BNF 53, 2007].
- Advise people using a LABA that they must not stop using their ICS.
- Advise people who have been prescribed salmeterol that they should not use it to relieve an acute asthma attack.
© NHS Institute for Innovation and Improvement